Liposomal Doxorubicin Market is Expected to Reach US$ 2,367.5 Million by 2034, Rising at a 6.3% CAGR | Future Market Insights Inc. NEWARK, Del, July 03, 2024 (GLOBE NEWSWIRE) -- The liposomal doxorubicin market is estimated to be worth USD 1,281.3 Million in 2024 and is projected to be valued at USD 2,367.5 Million in 2034....

Liposomal Doxorubicin Market to hit US$ 2.05 Billion by 2030 | Exclusive Report by Growth Plus Reports Pune, Oct. 27, 2022 (GLOBE NEWSWIRE) -- According to a new market research report titled, “Liposomal Doxorubicin Market by Drug Formulation (Lyophilized Powder and Doxorubicin Injection), by...

Rising Incidence of Cancer to Drive Doxorubicin Market at CAGR of 5.3% through 2026: Fact.MR Research United States, Rockville MD, May 04, 2022 (GLOBE NEWSWIRE) -- According to a recently published Fact.MR report, the global Doxorubicin Market is projected to grow at a compound annual rate (CAGR) of...

Liposomal Doxorubicin Market in U.S. to Surpass US$ 192.9 Million by 2027, Says Coherent Market Insights (CMI) SEATTLE, July 09, 2021 (GLOBE NEWSWIRE) -- According to Coherent Market Insights, the U.S. liposomal doxorubicin market is estimated to be valued at US$ 140.0 Million in 2020 and is expected to...